Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. Binding is isoform-specific. May regulate translation of target mRNAs.
Expressed in oocytes, granulosa cells of small and growing follicles, Leydig cells, spermatogonia and semen (at protein level). Expressed in testicular cancer (at protein level). Expressed weakly in heart, placenta, skeletal muscle, bone marrow, colon, kidney, salivary glands, testis and pancreas. Detected in fetal liver, fetal ovary, gonocytes and interstitial cells of the testis.
Belongs to the RRM IMP/VICKZ family. Contains 4 KH domains. Contains 2 RRM (RNA recognition motif) domains.
The third and fourth KH domains are important for binding to the untranslated region (UTR) of target mRNA.
Cytoplasm. Localized in cytoplasmic mRNP granules containing untranslated mRNAs. Localizes at the connecting piece and the tail of the spermatozoa.
Insulin like growth factor 2 mRNA binding protein 2 antibody
Insulin-like growth factor 2 mRNA-binding protein 2 antibody
VICKZ 2 antibody
VICKZ family member 2 antibody
Western blot - Anti-IGF2BP2 antibody (ab117809)
All lanes : Anti-IGF2BP2 antibody (ab117809) at 0.1 µg/ml
Lane 1 : Whole cell lysate from 293T cells at 50 µg Lane 2 : Whole cell lysate from 293T cells at 15 µg Lane 3 : Whole cell lysate from Jurkat cells at 50 µg Lane 4 : Whole cell lysate from HeLa cells at 50 µg
ab117809 at 1 µg/ml staining IGF2BP2 by WB, following immunoprecipitation of whole cell lysate from 293T cells.
Lane 1; IP using an antibody to an upstream epitope.
Lane 2; IP using ab117809 at 6 µg/mg lysate.
Lane 3; IP using control IgG.
1 mg of lysate was used for IP and 20% of IP was loaded. Detection utilised ECL with a 30 second exposure.